Table 1.
Summary of clinical data.
| Groups | EV71-infected patients | Controls (n = 95) | ||
|---|---|---|---|---|
| Stage II (n = 55) | Stage III (n = 42) | Stage IV (n = 30) | ||
| Female/male | 27/28 | 20/22 | 16/14 | 48/47 |
| Age (months), mean ± SD | 25.31 ± 10.24 | 26.55 ± 11.23 | 26.21 ± 10.47 | 26.11 ± 11.05 |
| High fever (>39°C >3 days at admission), n (%) | 33 (60.00) | 25 (59.52) | 20 (66.67) | 0 (0) |
| Vomiting, n (%) | 15 (27.27) | 13 (30.95) | 13 (43.33) | 0 (0) |
| Skin rash, n (%) | 52 (94.55) | 40 (95.24) | 29 (96.67) | 0 (0) |
| Oral ulcer, n (%) | 53 (96.36) | 42 (100) | 29 (96.67) | 0 (0) |
| Easily frightened, n (%) | 8 (14.55) | 10 (23.81) | 12 (40.00) | 0 (0) |
| Depression, n (%) | 16 (29.09) | 18 (42.86) | 25 (83.33) | 0 (0) |
| Abnormal breathing, n (%) | 9 (16.36) | 8 (19.05) | 15 (50.00) | 0 (0) |
| Increased heart rate, n (%) | 25 (45.45) | 26 (61.90) | 26 (86.67) | 0 (0) |
| GLU > 8.3 mmol/L, n (%) | 30 (54.55) | 30 (71.43) | 25 (83.33) | 0 (0) |
| CRT > 2 s, n (%) | 8 (14.55) | 25 (59.52) | 23 (76.67) | 0 (0) |
| WBC (×109/L), mean ± SD | 7.08 ± 3.41 | 8.74 ± 3.33 | 11.50 ± 3.37 | 6.78 ± 2.27 |
WBC: white blood cell.